• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性汗腺炎中炎症性关节炎的患病率及其预测因素。

Prevalence and Predictors of Inflammatory Arthritis in Hidradenitis Suppurativa.

机构信息

Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Division of Rheumatology, Department of Medicine, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.

出版信息

Exp Dermatol. 2024 Oct;33(10):e15194. doi: 10.1111/exd.15194.

DOI:10.1111/exd.15194
PMID:39397373
Abstract

Hidradenitis Suppurativa (HS) is a chronic, debilitating, auto-inflammatory condition often associated with inflammatory arthritis, significantly impacting patients' quality of life. Early diagnosis of both conditions is crucial for optimal management. The objective of this study was to determine the prevalence and factors associated with the development of inflammatory arthritis among HS patients. A cross-sectional study was conducted between November 2021 and February 2023 at an academic dermatology centre in Canada. Adult patients with HS were consecutively sampled, and 52 patients consented to participate and completed assessments. Variables examined included age, sex, HS severity, treatment, ethnicity, family history, lifestyle factors and comorbidities. The main outcomes were rheumatologist-confirmed inflammatory arthritis diagnosis and associated risk factors. Among 52 patients (24 males, 28 females; mean age: 37.4 years), 12 had inflammatory arthritis. Multivariate analysis revealed that Blacks (OR = 0.10, p < 0.001, CI: 0.026-0.343) and Asians (OR = 0.02, p < 0.001, CI: 0.005-0.109) had lower inflammatory arthritis odds compared to Whites. Every 1-year increase in age at HS onset correlated with a 1.17-fold increase in the odds of developing inflammatory arthritis (OR: 1.17, p < 0.001, CI: 1.12-1.24). Smoking (OR = 0.01, p < 0.001, CI: 0.002-0.49), hypertension (OR: 0.23, p = 0.04, CI: 0.057-0.930) and depression (OR: 0.12, p < 0.001, CI: 0.041-0.330) reduced inflammatory arthritis odds. White ethnicity and older age at HS onset were positively associated with inflammatory arthritis, while smoking, hypertension and depression were negatively associated. These findings suggest a distinct subset of HS patients with inflammatory arthritis that warrant further prospective studies. This study contributes to the understanding of inflammatory arthritis in HS patients and emphasises the importance of rheumatology referral during dermatologic clinic visits.

摘要

化脓性汗腺炎(HS)是一种慢性、使人虚弱的自身炎症性疾病,常与炎症性关节炎相关,显著影响患者的生活质量。这两种疾病的早期诊断对优化管理至关重要。本研究旨在确定 HS 患者中炎症性关节炎的患病率和相关因素。这是一项在加拿大一所学术皮肤科中心进行的横断面研究,于 2021 年 11 月至 2023 年 2 月间进行。连续抽取 HS 成年患者进行采样,52 名患者同意参与并完成评估。检查的变量包括年龄、性别、HS 严重程度、治疗方法、种族、家族史、生活方式因素和合并症。主要结局是风湿科医生确诊的炎症性关节炎诊断和相关危险因素。在 52 名患者(24 名男性,28 名女性;平均年龄:37.4 岁)中,有 12 名患有炎症性关节炎。多变量分析显示,与白人相比,黑人(OR=0.10,p<0.001,CI:0.026-0.343)和亚洲人(OR=0.02,p<0.001,CI:0.005-0.109)发生炎症性关节炎的几率较低。HS 发病年龄每增加 1 岁,发生炎症性关节炎的几率就会增加 1.17 倍(OR:1.17,p<0.001,CI:1.12-1.24)。吸烟(OR=0.01,p<0.001,CI:0.002-0.49)、高血压(OR:0.23,p=0.04,CI:0.057-0.930)和抑郁症(OR:0.12,p<0.001,CI:0.041-0.330)降低了炎症性关节炎的几率。白人种族和 HS 发病年龄较大与炎症性关节炎呈正相关,而吸烟、高血压和抑郁症则呈负相关。这些发现表明存在具有炎症性关节炎的特定 HS 患者亚群,这需要进一步的前瞻性研究。本研究有助于了解 HS 患者的炎症性关节炎,并强调在皮肤科就诊期间进行风湿病转诊的重要性。

相似文献

1
Prevalence and Predictors of Inflammatory Arthritis in Hidradenitis Suppurativa.化脓性汗腺炎中炎症性关节炎的患病率及其预测因素。
Exp Dermatol. 2024 Oct;33(10):e15194. doi: 10.1111/exd.15194.
2
Prevalence of Musculoskeletal Symptoms in Patients With Hidradenitis Suppurativa and Associated Factors: Cross-Sectional Study.化脓性汗腺炎患者肌肉骨骼症状的患病率及相关因素:横断面研究。
JMIR Dermatol. 2024 Aug 22;7:e58989. doi: 10.2196/58989.
3
Association between Hidradenitis Suppurativa and Inflammatory Arthritis: A Systematic Review and Meta-Analysis.化脓性汗腺炎与炎症性关节炎的相关性:系统评价和荟萃分析。
Dermatology. 2021;237(5):740-747. doi: 10.1159/000514582. Epub 2021 Mar 26.
4
Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.化脓性汗腺炎和银屑病的共病率:详细的人口统计学、疾病严重程度和合并症模式。
Dermatology. 2021;237(5):759-768. doi: 10.1159/000511868. Epub 2020 Dec 16.
5
Incidence of anxiety disorder in adults with hidradenitis suppurativa.化脓性汗腺炎成年患者中焦虑障碍的发病率。
Br J Dermatol. 2024 Aug 14;191(3):351-356. doi: 10.1093/bjd/ljae139.
6
Association of metabolic syndrome and hidradenitis suppurativa.代谢综合征与化脓性汗腺炎的相关性。
JAMA Dermatol. 2014 Dec;150(12):1273-80. doi: 10.1001/jamadermatol.2014.1165.
7
Hidradenitis suppurativa and pemphigus: a cross-sectional study.化脓性汗腺炎与天疱疮:一项横断面研究。
Arch Dermatol Res. 2020 Sep;312(7):501-505. doi: 10.1007/s00403-020-02040-x. Epub 2020 Feb 7.
8
High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation.在中轴型脊柱关节炎患者中,化脓性汗腺炎症状的高发率:一种可能的新的关节外表现。
Semin Arthritis Rheum. 2019 Feb;48(4):611-617. doi: 10.1016/j.semarthrit.2018.03.010. Epub 2018 Mar 20.
9
Hidradenitis Suppurativa in the Pediatric Population: An International, Multicenter, Retrospective, Cross-sectional Study of 481 Pediatric Patients.儿童化脓性汗腺炎:一项国际多中心回顾性横断面研究,纳入 481 例儿科患者。
JAMA Dermatol. 2021 Apr 1;157(4):385-391. doi: 10.1001/jamadermatol.2020.5435.
10
Incidence, prevalence, and predictors of inflammatory arthritis in patients with hidradenitis suppurativa: a systematic review and meta-analysis.化脓性汗腺炎患者中炎症性关节炎的发病率、患病率和预测因素:系统评价和荟萃分析。
Int J Dermatol. 2022 Sep;61(9):1069-1079. doi: 10.1111/ijd.15860. Epub 2021 Aug 25.

引用本文的文献

1
Transcriptomic Signatures and Molecular Pathways in Hidradenitis Suppurativa-A Narrative Review.化脓性汗腺炎的转录组特征和分子途径——一篇叙述性综述
Int J Mol Sci. 2025 Aug 9;26(16):7704. doi: 10.3390/ijms26167704.
2
IRAK4 Targeting: A Breakthrough Approach to Combat Hidradenitis Suppurativa.靶向IRAK4:治疗化脓性汗腺炎的突破性方法。
Biologics. 2025 Jun 30;19:387-397. doi: 10.2147/BTT.S525106. eCollection 2025.